Casdin Partners Master Fund, L.P. - Apr 30, 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
10%+ Owner
Signature
Casdin Partners Master Fund, LP, By: Casdin Partners GP, LLC,, its General Partner, By: /s/ Eli Casdin, Managing Member
Stock symbol
BLFS
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 05:05 PM
Previous filing
Mar 20, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock, par value $.001 per share Other $2.63M +150K +1.75% $17.54 8.71M Apr 30, 2024 Direct F1, F2
transaction BLFS Common Stock, par value $.001 per share Other -$2.63M -150K -100% $17.54 0 Apr 30, 2024 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cross-trade, pursuant to which a client of Casdin Capital, LLC ("Casdin Capital") transferred 150,000 shares of common Stock, par value $.001 per share to Casdin Partners Master Fund, L.P. (the "Master Fund").
F2 The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.
F3 The securities were owned directly by a client of Casdin Capital and were deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin GP, the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.